Decreased contractile effect of endothelin-1 on hyperplastic prostate

General Pharmacology

Volumn 27, Issue 6, 1996, Pages 1061-1065

  Moriyama, Nobuo ^a   Kurimoto, Sigeharu ^a   Miyata, Noriyuki ^b   Yamaura, Hiroko ^b   Yamazaki, Ryuzaburo ^b   Sudoh, Katsumi ^c   Inagaki, Osamu ^c   Takenaka, Toichi ^c   Kawabe, Kazuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

Author keywords

benign prostatic hyperplasia; endothelin 1; prostate (human)

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; IODINE 125; PHENYLEPHRINE;

ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SMOOTH MUSCLE CONTRACTILITY; TISSUE DISTRIBUTION;

EID: 0030250493     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)00117-4     Document Type: Article

References (13)

1. Aoki D., Kawashima H, Nozawa S., Udagawa Y., Iiaika R. and Hirano H. (1989) Difference in lectin binding patterns of normal human endometrium between proliferative and secretory phases. Histochemistry 92, 177-184.
2. Bartsch G., Frick J., Rüegg I., Bucher M., Holliger O., Oberholzer M. and Rohr H. P. (1979) Electron microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J. Urol 122, 481-486.
3. Bradford M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Henry P., Rigby P., Self G., Preuss J. and Goldie R. (1990) Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br. J. Pharmac. 100, 786-792.
5. Kobayashi S., Tang R., Wang B., Opgenorth T., Langenstroer P., Shapiro E. and Lepor H. (1994a) Binding and functional properties of endothelin receptor subtypes in the human prostate. Mol. Pharmac. 45, 306-311.
6. Kobayashi S., Tang R., Wang B., Opgenorth T., Stein E., Shapiro E. and Lepor H. (1994b) Localization of endothelin receptors in the human prostate. J. Urol. 151, 763-766.
7. Kondo S. and Morita T. (1993) Effect of benign prostatic hypertrophy on the endothelin-1 receptor density in human urinary bladder and prostate. Nippon Hinyoukika Gakkai Zasshi 84, 1821-1827 (in Japanese).
8. Langenstroer P., Tang R., Shapiro E., Divish B., Opgenorth T. and Lepor H. (1993) Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. J. Urol. 150, 495-499.
9. Maggi C. A., Giuliani S., Patacchini R., Santiciotli P., Turini D., Barbanti G. and Meli A. (1989) Potent contractile activity of endothelin on the human isolateral urinary bladder. Br. J. Pharmac. 96, 755-757.
10. Morita T., Ando K., Kihara K., Matsumura T., Kamai T. and Oshima H. (1993) Effects of endothelin-1 on the smooth muscle contractivity of human urinary bladder, spermatic cord and prostatic adenoma. Nippon Hinyoukika Gakkai Zasshi 84, 1649-1654 (in Japanese).
11. Munson P. J. and Rodbard D. (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
12. Sakurai T., Yanagisawa M. and Masaki T. (1992) Molecular characterization of endothelin receptors. TIPS 13, 103-108.
13. Yanagisawa H., Kurihara M., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K. and Masaki T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415.